Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ys Biopharma Co. Ltd (YS)

Ys Biopharma Co. Ltd (YS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 94,919
  • Shares Outstanding, K 93,058
  • Annual Sales, $ 100,000 K
  • Annual Income, $ -21,170 K
  • EBIT $ -11 M
  • EBITDA $ -15 M
  • 60-Month Beta 0.51
  • Price/Sales 1.20
  • Price/Cash Flow N/A
  • Price/Book 1.42
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.03
  • Most Recent Earnings $-0.12 on 04/19/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7040 +44.89%
on 04/30/24
1.1000 -7.27%
on 05/24/24
+0.2100 (+25.93%)
since 04/24/24
3-Month
0.3800 +168.42%
on 03/01/24
1.1000 -7.27%
on 05/24/24
+0.6251 (+158.29%)
since 02/23/24
52-Week
0.3503 +191.18%
on 02/02/24
1.7800 -42.70%
on 06/13/23
-0.2700 (-20.93%)
since 05/24/23

Most Recent Stories

More News
LakeShore Biopharma Initiates Biologics License Application of PIKA Rabies Vaccine to the Drug Regulatory Authority of Pakistan

YS : 1.0200 (+12.45%)
LSB : 0.6270 (-20.68%)
YS Biopharma Announces First Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

YS : 1.0200 (+12.45%)
YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

YS : 1.0200 (+12.45%)
YS Biopharma to Participate in Participate in Citi's 18th Annual Biopharma Conference

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

YS : 1.0200 (+12.45%)
YS Biopharma Announces Purchase of Shares by Company Officers

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

YS : 1.0200 (+12.45%)
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

YS : 1.0200 (+12.45%)
YS Biopharma Announces Financial Results for Fiscal Year 2023 Ended March 31, 2023

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

YS : 1.0200 (+12.45%)
YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

YS : 1.0200 (+12.45%)
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. Investors to Inquire About Securities Class Action Investigation - YS, SMIH

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of YS...

YS : 1.0200 (+12.45%)
YS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical Trial Approval From Philippines FDA

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

YS : 1.0200 (+12.45%)

Business Summary

YS Biopharma Co. Ltd. is a biopharmaceutical company. It focuses on discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The company operates principally in China, the United States, Singapore, the United...

See More

Key Turning Points

3rd Resistance Point 1.3133
2nd Resistance Point 1.2067
1st Resistance Point 1.1133
Last Price 1.0200
1st Support Level 0.9133
2nd Support Level 0.8067
3rd Support Level 0.7133

See More

52-Week High 1.7800
Fibonacci 61.8% 1.2339
Fibonacci 50% 1.0652
Last Price 1.0200
Fibonacci 38.2% 0.8964
52-Week Low 0.3503

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar